The given chart illustrates the proportion of total income of a medical company between 2002 and 2006 in 3 distinct areas, including Asia, Europe and America.
Looking from an overall perspective, it is readily apparent that the figure for company’s sale in Asia had a tendency to increase, while those for Europe and America fluctuated insignificantly. America region topped the list at the beginning, whereas Asia stood at the highest sales position towards the end.
At the onset, the majority income of the company was made by America, accounting for 41%, followed by Europe and America with 34% and 25%, respectively. In 2003, the sales earned by America and Europe were approximately the same at 35% before Europe had a rise in income at 38% in the next year. Asia region had less total sales at 30% in 2003 and raised 5% in income in 2004 in comparison to only 27% of America.
In 2005 and 2006, sales in Asia were overwhelmingly popular, as 37% and 40% of financial amounts were made, in that order. The drug company had less sales in Europe with 34% for 2005 category and 30% for 2006 category, compared to the negligible gap between the data for America in two years, standing at 29% for the former and 30% for the latter.